Remote Cardiovascular Hypertension Program Enhanced Blood Pressure Control During the COVID‐19 Pandemic
Journal of the American Heart Association · 21.03.2023 · 12 (6)
DOI: 10.1161/jaha.122.027296 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Journal of the American Heart Association, erschienen am 21.03.2023. Verfasst von Simin Gharib Lee und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Department of Medicine Brigham and Women's Hospital and Harvard Medical School Boston MA. Hauptthemen laut MEDLINE: COVID-19, Hypertension. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.
Abstract (Originalsprache)
Background The COVID‐19 pandemic disrupted traditional health care; one fallout was a drastic decrease in blood pressure (BP) assessment. We analyzed the pandemic's impact on our existing remote hypertension management program's effectiveness and adaptability. Methods and Results This retrospective observational analysis evaluated BP control in an entirely remote management program before and during the pandemic. A team of pharmacists, nurse practitioners, physicians, and nonlicensed navigators used an evidence‐based clinical algorithm to optimize hypertensive treatment. The algorithm was adapted during the pandemic to simplify BP control. Overall, 1256 patients (605 enrolled in the 6 months before the pandemic shutdown in March 2020 and 651 in the 6 months after) were a median age of 63 years old, 57% female, and 38.2% non‐White. Among enrolled patients with sustained hypertension, 51.1% reached BP goals. Within this group, rates of achieving goal BP improved to 94.6% during the pandemic from 75.8% prepandemic ( P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cardiology, Department of Medicine Brigham and Women's Hospital and Harvard Medical School Boston MA.
- Harvard Medical School Boston MA.
- Division of General Internal Medicine and Primary Care Brigham and Women's Hospital Boston MA.
- Department of Pharmacy Services Boston MA.
- Division of Endocrinology, Diabetes and Hypertension Brigham and Women's Hospital Boston MA.
ORCID-Profile: Simin Gharib Lee, Alexander J Blood, Christopher P Cannon, William J Gordon, Hunter Nichols, David Zelle, Benjamin M Scirica, Naomi D L Fisher
Förderung
- NHLBI NIH HHS
Zitieren
APA
Lee, S. G., Blood, A. J., Cannon, C. P., Gordon, W. J., Nichols, H., Zelle, D., Scirica, B. M., & Fisher, N. D. L. (2023). Remote Cardiovascular Hypertension Program Enhanced Blood Pressure Control During the COVID‐19 Pandemic. Journal of the American Heart Association, 12(6). https://doi.org/10.1161/jaha.122.027296
Vancouver
Lee SG, Blood AJ, Cannon CP, Gordon WJ, Nichols H, Zelle D, et al. Remote Cardiovascular Hypertension Program Enhanced Blood Pressure Control During the COVID‐19 Pandemic. Journal of the American Heart Association. 2023;12(6). doi:10.1161/jaha.122.027296
BibTeX
@article{Lee2023,
author = {Lee, Simin Gharib and Blood, Alexander J and Cannon, Christopher P and Gordon, William J and Nichols, Hunter and Zelle, David and Scirica, Benjamin M and Fisher, Naomi D L},
title = {Remote Cardiovascular Hypertension Program Enhanced Blood Pressure Control During the COVID‐19 Pandemic},
journal = {Journal of the American Heart Association},
year = {2023},
volume = {12},
number = {6},
doi = {10.1161/jaha.122.027296}
}
EUVIMED